Document is current
Any future updates will be listed below
-
Authors
Olmeda, Fabrizio https://orcid.org/0009-0009-2107-7887
Lohoff, Tim
Kafetzopoulos, Ioannis
Clark, Stephen J.
Benson, Laura https://orcid.org/0000-0002-7239-6126
Santos, Fatima https://orcid.org/0000-0002-3854-4084
Krueger, Felix https://orcid.org/0000-0002-5513-3324
Walker, Simon https://orcid.org/0000-0001-9185-4922
Reik, Wolf https://orcid.org/0000-0003-0216-9881
Rulands, Steffen https://orcid.org/0000-0001-6398-1553
- License Information
-
More Information
Article History
Received: 23 July 2025
Accepted: 23 March 2026
First Online: 29 April 2026
Competing interests
: I.K., S.J.C., L.B. and W.R. are employees of Altos Labs. W.R. is a consultant and shareholder of Biomodal. T.L. is employed on a full-time basis by Forbion, a venture capital firm specializing in investments within the life sciences sector. Forbion provides funding to a range of life science companies. The analyses, views and information presented in this paper are solely those of the author and are provided for academic and informational purposes only. They do not represent the views, positions or investment strategies of Forbion or any of its affiliated entities. The remaining authors declare no competing interests.
